EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress

Ads

You May Also Like

Inventiva: First-half 2018 financial results and business update

Inventiva: First-half 2018 financial resultsand business update Continuation of the clinical development of lanifibranor ...

Cerner and Lumeris Will Launch Offering to Reduce Complexities for Health Systems Delivering Value-Based Care

Collaboration will create an EHR-agnostic offering, Maestro Advantage(TM), designed to help providers who participate ...

GreeneStone Adds Two New Directors to the Board

TORONTO, Nov. 05, 2015 (GLOBE NEWSWIRE) -- GreeneStone Healthcare Corporation (OTCQB:GRST) (“GreeneStone” “GRST” or ...